###### Abstract
This is because they exhibit anti-inflammatory, antiproliferative and immunosuppressive effects, as well as antipruritic effects [11]. Medium- and high-potency steroids, such as triamcinolone acetonide 0.1%, are used to treat acute inflammatory lesions. In contrast, lower-potency steroids are used on areas covered by a thinner layer of skin, such as the eyelids, facial skin or genitals, because of the risk of atrophy. In a situation where skin lesions occupy more than 20%, general corticosteroid treatment is implemented [11; 15; 16]. As noted by the authors [17], long-term use of steroids has been associated with many side effects such as rosacea, acne-like rashes, skin atrophy and telangiectasias. A summary of various therapeutic strategies is presented in Table 1. \begin{table}
\begin{tabular}{l l} \hline \hline \multicolumn{1}{c}{**Treatment In Atopic Dermatitis:**} \\ \hline \multirow{2}{*}{Dependent on the severity of AD} & During exacerbations—topical application of corticosteroids (hydrocortisone, prednisolone) \\  & and calcineurin inhibitors (pimecrolimus and tacrolimus) \\ \hline Maintenance (for chronic lesions or periodic exacerbations) & Periodic use of topical corticosteroids and calcineurin inhibitors (to prevent recurrence of skin inflammation) \\ \hline \hline \end{tabular}
\end{table} 
Table 1: Summary of therapeutic strategies for atopic dermatitis for all age groups [18; 19]. Products that reduce the use of steroids in the treatment of AD are emollients, which, according to the authors of [20], have significantly reduced the need for patients to use corticosteroids. The authors of [21] report that the use of emollients is associated with numerous beneficial effects, such as reducing the number of AD exacerbations, prolonging remission periods, reducing eczematous lesions and reducing the amount of corticosteroids needed to achieve a similar therapeutic effect. It has been confirmed that emollients in combination with active treatment (among other steroids) produce significantly better results than steroids alone [21]. Currently, the typical therapeutic strategy undertaken in patients with atopic dermatitis is the simultaneous use of glucocorticoids and emollients [21]. One method that combines emollients and steroids is the use of wet-wrap treatment. It involves applying two layers of dressings to the skin. The inner layer is saturated with emollients and a glucocorticoidoid, while the outer layer remains dry. Wet-wrap treatment reduces the sensation of pruritus, cools the skin and prolongs the sensation of hydration, while the use of topical glucocorticoids in wet dressings increases their absorption from the skin surface [10]. Emollients achieve the greatest efficacy in mild forms of AD [4; 22]. Studies confirm that the concomitant use of glucocorticoids during exacerbations and maintenance of regular skin care with emollients can beneficially manage atopic dermatitis and prevent exacerbations [20]. Their action is based on restoring the integrity of the epidermal barrier, which counteracts xerosis and reduces persistent itching, which is one of the most troublesome symptoms. They are commonly used to treat various disorders such as psoriasis, keratosis disorders and xeroderma [4; 22]. Emollients can be used either as creams, emulsions or lotions, or as a form of bath preparation as shower gels or shampoos [1]. The use of emollient-like ingredients has been popular since ancient times. The use of substances such as honeys or natural oils, among others, in treatment was already known in ancient Egypt, Rome and China [1; 5]. Most likely, the first known description of a patient with AD was created by [PERSON], and the patient was the famous Emperor [PERSON] [5]. This information confirms that atopic dermatitis is a disease that people have faced since the dawn of time. It is for this reason that today, on the basis of accumulated knowledge, we are able to develop more and more targeted and effective therapy for patients with atopic dermatitis [1; 5].